Jetzt zu CONTOUR^®NEXT wechseln, weil…

Die von Ascensia Diabetes Care zur Verfügung gestellten Informationen dienen der allgemeinen Information. Sie sind nicht als medizinischer Rat, Diagnose oder Behandlung gedacht und sollten nicht den Rat Ihres medizinischen Betreuers ersetzen.

Quellen:

1) Stedman M et al. J Diabetes Sci Technol. 2020 Mar 14; doi: 10.1177/1932296820905880. Online ahead of print. 2) CONTOUR^®NEXT User Guide (connected) BGMS User Guide, Rev. 05/19. 3) Grady M et al. J Diabetes Sci Technol. 2018;12:1211–1219. 4) Unveröffentlichte Daten. Verfügbar auf Anfrage. N=326. Ascensia Diabetes care. CNext/CTV3 Study. Protocol no. GCA-PRO-2018-006-01 5) Richardson J et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the virtual 20th Annual Diabetes Technology Meeting (DTM). 12 November 2020.
©2021 Ascensia Diabetes Care Holdings AG. All rights reserved.Ascensia, the Ascensia Diabetes Care logo, Contour, smartLIGHT and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.
Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Date of preparation: February 2021. PP-CN-Mtr-GBL-0003